Shanghai - Delayed Quote CNY
Innovita Biological Technology Co., Ltd. (688253.SS)
33.40
-0.41
(-1.21%)
At close: 3:00:04 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Xiujie Zhang | GM & Director | -- | -- | 1971 |
| Ms. Xiujuan Zhao | Financial Director & Director | -- | -- | 1974 |
| Ying Zhao | Accounting Supervisor | -- | -- | -- |
| Mr. Xiaogang Zhang | Deputy GM & Director | -- | -- | 1964 |
| Mr. Fukang Chen | Board Secretary | -- | -- | 1984 |
Innovita Biological Technology Co., Ltd.
Building 6, Yard 1
Floor 1, Floor 2 Haiying Road Fengtai District
Beijing, 100070
China
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 547
Description
Innovita Biological Technology Co., Ltd. engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products. The company offers pathogen detection and joint detection of multiple pathogen; emergency outpatient testing; coronavirus testing; respiratory infections solutions; pregnancy test; hepatitis virus testing ; and enterovirus testing . The company was founded in 2006 and is based in Beijing, China.
Corporate Governance
Innovita Biological Technology Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
June 6, 2024 at 12:00 AM UTC
Ex-Dividend Date